Share this Page:
An updated version of the COVID-19 vaccine that targets two coronavirus variants (known as a “bivalent” vaccine) has been approved for adult booster doses by the UK medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). The vaccine is made by Moderna and meets the UK regulator’s standards of safety, quality and effectiveness.
Each dose of the booster vaccine targets the original SARS-CoV-2 virus strain from 2020 and the Omicron variant.
This is the first bivalent COVID-19 booster vaccine to be approved for use in the world.